Cargando…
The Antidiabetic Activities of Neocryptotanshinone: Screened by Molecular Docking and Related to the Modulation of PTP1B
The aim of this study was to provide a practical experimental basis for the development of Neocryptotanshinone (NCTS) as an effective hypoglycemic drug and a theoretical method for the rapid screening of natural compounds with hypoglycemic effects. Molecular docking was used to screen the most suita...
Autores principales: | Hao, Jie, Qian, Zhiming, Liu, Zijian, Zhang, Guirong, Wang, Di, Han, Weiwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330310/ https://www.ncbi.nlm.nih.gov/pubmed/35893885 http://dx.doi.org/10.3390/nu14153031 |
Ejemplares similares
-
Molecular docking and virtual screening for novel protein tyrosine phosphatase 1B (PTP1B) inhibitors
por: Rao, Pasupuleti Sreenivasa, et al.
Publicado: (2012) -
Neocryptotanshinone inhibits lipopolysaccharide-induced inflammation in RAW264.7 macrophages by suppression of NF-κB and iNOS signaling pathways
por: Wu, Chuanhong, et al.
Publicado: (2015) -
Docking of oxalyl aryl amino benzoic acid derivatives into PTP1B
por: Verma, Neelam, et al.
Publicado: (2008) -
Antiobesity and Antidiabetes Effects of a Cudrania tricuspidata Hydrophilic Extract Presenting PTP1B Inhibitory Potential
por: Kim, Dae Hoon, et al.
Publicado: (2016) -
The importance of including the C-terminal domain of PTP1B(1-400) to identify potential antidiabetic inhibitors
por: Coronell-Tovar, Andrea, et al.
Publicado: (2023)